Celldex 制药 CLDX
$29.87 +$1.60 (+5.66%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $30.00 +0.44%
开盘$27.85
昨收$28.27
当日区间$27.82 – $30.15
成交量926.3K
市值$2.35B
市盈率（TTM）–
股息率–
财报
财报日平均波动±6.9%近16次财报
收涨次数8 / 1650% 的概率
最佳反应+11.3%
最差反应-21.0%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2023/Q4 | 26 Feb 2024 | After Market | ±16.1% | +5.83% | 符合区间 |
| 2021/Q4 | 28 Feb 2022 | After Market | ±17.3% | +5.62% | 符合区间 |
| 2020/Q2 | 6 Aug 2020 | None | ±33.4% | -4.87% | 符合区间 |
| 2019/Q2 | 7 Aug 2019 | After Market | – | +2.31% | – |
| 2018/Q4 | 7 Mar 2019 | After Market | – | +10.87% | – |
| 2018/Q2 | 8 Aug 2018 | After Market | – | -6.76% | – |
| 2017/Q4 | 7 Mar 2018 | None | – | +11.34% | – |
| 2017/Q2 | 8 Aug 2017 | None | – | -1.17% | – |
| 2016/Q4 | 14 Mar 2017 | After Market | – | +3.33% | – |
| 2016/Q2 | 8 Aug 2016 | None | – | -3.00% | – |
| 2015/Q4 | 25 Feb 2016 | Pre Market | – | +0.58% | – |
| 2015/Q2 | 10 Aug 2015 | After Market | – | -20.56% | – |
| 2014/Q4 | 24 Feb 2015 | Pre Market | – | +2.93% | – |
| 2014/Q3 | 4 Nov 2014 | After Market | – | -20.99% | – |
| 2014/Q2 | 6 Aug 2014 | None | – | -0.52% | – |
| 2013/Q4 | 3 Mar 2014 | None | – | -10.06% | – |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$22,000.00-97.0% YoY
营业利润-$80.62M-26.3% YoY
净利润-$73.50M-29.9% YoY
摊薄每股收益-$0.94-10.6% YoY
自由现金流-$60.59M-35.4% YoY
经营现金流-$57.41M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
营业利润率-206,220.3%
净利率-190,220.9%
净资产收益率-43.9%
资产收益率-40.8%
投入资本回报率-43.6%
流动比率11.82
负债/资产比率8.7%
现金及投资$717.59M
总负债$3.35M
净现金（净负债）$714.24M
暂无评论——快来第一个聊聊 CLDX。
登录后参与讨论。